Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
Progyny (NASDAQ: PGNY), a leader in women's health and family building, has announced two key executive appointments to support its growth and innovation strategy. Melissa Cummings joins as the company's first Chief Operating Officer (COO) and Geoffrey Clapp as its first Chief Product Officer (CPO).
Cummings brings 30 years of healthcare experience, most recently serving as Executive Vice President and Chief Customer Officer at Blue Cross & Blue Shield of Rhode Island. Clapp, with over two decades in healthcare technology, previously held the position of Senior Vice President and Head of Strategy at Optum Health Solutions.
The appointments come as Progyny experiences significant growth, now serving more than 530 employers with 6.7 million contracted lives. The company has expanded its services to include Parent and Child Well-being programs and doula support, positioning itself as a comprehensive solution for reproductive health care.
Progyny (NASDAQ: PGNY), leader nella salute femminile e nella costruzione della famiglia, ha annunciato due nomine chiave nel suo team esecutivo per sostenere la strategia di crescita e innovazione. Melissa Cummings entra come prima Chief Operating Officer (COO) dell'azienda e Geoffrey Clapp come primo Chief Product Officer (CPO).
Cummings porta con sé 30 anni di esperienza nel settore sanitario, avendo ricoperto recentemente il ruolo di Executive Vice President e Chief Customer Officer presso Blue Cross & Blue Shield del Rhode Island. Clapp, con oltre vent'anni di esperienza nella tecnologia sanitaria, è stato in precedenza Senior Vice President e Head of Strategy presso Optum Health Solutions.
Le nomine arrivano in un momento di forte crescita per Progyny, che ora serve più di 530 aziende con 6,7 milioni di persone assicurate. L'azienda ha ampliato i suoi servizi includendo programmi per il benessere di genitori e bambini e supporto doula, affermandosi come una soluzione completa per la cura della salute riproduttiva.
Progyny (NASDAQ: PGNY), líder en salud femenina y construcción de familias, ha anunciado dos nombramientos ejecutivos clave para apoyar su estrategia de crecimiento e innovación. Melissa Cummings se incorpora como la primera Directora de Operaciones (COO) de la empresa y Geoffrey Clapp como su primer Director de Producto (CPO).
Cummings aporta 30 años de experiencia en el sector salud, habiendo sido recientemente Vicepresidenta Ejecutiva y Directora de Atención al Cliente en Blue Cross & Blue Shield de Rhode Island. Clapp, con más de dos décadas en tecnología sanitaria, ocupó anteriormente el puesto de Vicepresidente Senior y Jefe de Estrategia en Optum Health Solutions.
Estos nombramientos llegan en un momento de crecimiento significativo para Progyny, que actualmente atiende a más de 530 empleadores con 6.7 millones de vidas contratadas. La empresa ha ampliado sus servicios para incluir programas de bienestar para padres e hijos y apoyo de doula, posicionándose como una solución integral para el cuidado de la salud reproductiva.
Progyny (NASDAQ: PGNY)는 여성 건강 및 가족 형성 분야의 선두주자로서 성장과 혁신 전략을 지원하기 위해 두 명의 핵심 임원 임명을 발표했습니다. Melissa Cummings가 회사 최초의 최고운영책임자(COO)로, Geoffrey Clapp가 최초의 최고제품책임자(CPO)로 합류했습니다.
Cummings는 30년간의 의료 경험을 보유하고 있으며, 최근에는 로드아일랜드의 Blue Cross & Blue Shield에서 최고고객책임자 및 수석부사장으로 재직했습니다. Clapp는 20년 이상의 의료 기술 경력을 가지고 있으며, 이전에는 Optum Health Solutions에서 전략 담당 수석부사장으로 근무했습니다.
이번 임명은 Progyny가 530개 이상의 고용주와 670만 명의 계약자를 지원하며 크게 성장하는 시점에 이루어졌습니다. 회사는 부모 및 아동 복지 프로그램과 도울라 지원 서비스를 포함하도록 서비스를 확장하여 생식 건강 관리에 대한 종합적인 솔루션으로 자리매김하고 있습니다.
Progyny (NASDAQ : PGNY), leader dans la santé des femmes et la construction familiale, a annoncé deux nominations clés au sein de sa direction pour soutenir sa stratégie de croissance et d'innovation. Melissa Cummings rejoint l'entreprise en tant que première Directrice des Opérations (COO) et Geoffrey Clapp en tant que premier Directeur Produit (CPO).
Cummings apporte 30 ans d'expérience dans le secteur de la santé, ayant récemment occupé le poste de Vice-Présidente Exécutive et Directrice de la Relation Client chez Blue Cross & Blue Shield du Rhode Island. Clapp, avec plus de vingt ans d'expérience en technologie de santé, était auparavant Vice-Président Senior et Responsable de la Stratégie chez Optum Health Solutions.
Ces nominations interviennent alors que Progyny connaît une croissance significative, desservant désormais plus de 530 employeurs avec 6,7 millions de personnes couvertes. L'entreprise a élargi ses services pour inclure des programmes de bien-être pour parents et enfants ainsi qu'un soutien par des doulas, se positionnant comme une solution globale pour les soins de santé reproductive.
Progyny (NASDAQ: PGNY), ein führendes Unternehmen im Bereich Frauengesundheit und Familienaufbau, hat zwei wichtige Führungspositionen besetzt, um seine Wachstums- und Innovationsstrategie zu unterstützen. Melissa Cummings tritt als erste Chief Operating Officer (COO) des Unternehmens bei, und Geoffrey Clapp als erster Chief Product Officer (CPO).
Cummings bringt 30 Jahre Erfahrung im Gesundheitswesen mit und war zuletzt Executive Vice President und Chief Customer Officer bei Blue Cross & Blue Shield in Rhode Island. Clapp verfügt über mehr als zwei Jahrzehnte Erfahrung in der Gesundheitstechnologie und war zuvor Senior Vice President und Leiter der Strategie bei Optum Health Solutions.
Die Ernennungen erfolgen in einer Phase bedeutenden Wachstums für Progyny, das inzwischen mehr als 530 Arbeitgeber mit 6,7 Millionen versicherten Personen betreut. Das Unternehmen hat seine Dienstleistungen um Programme für das Wohlbefinden von Eltern und Kindern sowie Doula-Unterstützung erweitert und positioniert sich damit als umfassende Lösung für die reproduktive Gesundheitsversorgung.
- Strategic expansion of executive team with experienced healthcare leaders
- Strong market presence with 530+ employer clients and 6.7 million contracted lives
- Service portfolio expansion with new Parent and Child Well-being and doula support programs
- None.
The leadership additions support the company’s continued ability to scale as it delivers the right care model for women’s health and family building
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women’s health and family building, today announced the appointments of Melissa Cummings as the company’s first Chief Operating Officer (COO) and Geoffrey Clapp as its first Chief Product Officer (CPO). The additions to the executive leadership team will extend Progyny’s ability to further drive operational excellence, advance innovation in product design and member experience, and continue to address care gaps and unmet needs across the spectrum of family building and women’s health – from preconception to fertility and menopause.
“Progyny has established itself at the forefront of building and delivering the right care model for women’s health and family building. As we continue down the path of growth and innovation, we are intentional about bringing in visionary leaders who can accelerate our momentum and expand our impact,” said Pete Anevski, CEO, Progyny. “Melissa and Geoffrey bring the healthcare industry expertise and passion that will power and scale the next stage of our superior solutions and services.”
Cummings is a strategic, data-driven leader with a deep understanding of healthcare operations and a proven track record in general management, payer operations, and customer experience. Her impressive 30-year career in healthcare, includes serving most recently as Executive Vice President and Chief Customer Officer at Blue Cross & Blue Shield of Rhode Island, and prior to that as Vice President, Strategic Product Solutions at Aetna.
“There’s never been a more important time to rethink how women and families have traditionally been supported throughout their health journeys,” said Cummings. “Progyny’s unique model, unparalleled clinical outcomes, and commitment to high-touch care are setting a new standard in healthcare. I’m honored to join at such a transformative point in the company’s journey, and I’m excited to help scale its mission and impact even further.”
Complementing Cummings’ experience is Clapp who brings more than two decades of experience in healthcare technology, start-up innovation, engineering, and product development. As a Senior Vice President as well as Head of Strategy, Optum Health Solutions, he drove innovation that helped significantly increase earnings for both the Renal Care and Organ Transplant products, rebuilding them from the ground up. At Progyny, Clapp will lead product development and strategy and define the development roadmap for scalable, high-impact solutions that expand access to critical family building and women’s health care.
"There are few companies out there that have the passion and resources to impact the women’s health space at scale,” said Clapp “I’m excited to bring my years of experience in leading product to Progyny, where we’re anticipating what members will need tomorrow while delivering meaningful impact today.”
These appointments come at a time of significant momentum for Progyny. The company now serves more than 530 leading employers with 6.7 million contracted lives, offering solutions that span the reproductive health journey. With the latest addition of its Parent and Child Well-being program and doula support, Progyny continues to evolve into a single, trusted solution delivering value-based care, clinical excellence, and consistently superior outcomes.
For more information about Progyny’s leadership and integrated solutions, visit www.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
What strategic appointments did Progyny (PGNY) announce in April 2025?
How many contracted lives does Progyny (PGNY) currently serve?
What is Melissa Cummings' background before joining Progyny (PGNY)?
What new services has Progyny (PGNY) recently added to its healthcare offerings?
